SCHEMBL29986347

SCHEMBL29986347

NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)NCC(=O)O

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ OPRD1 P41143 5/20 0.49
▸ CCKAR P32238 3/20 0.49
▸ CCKBR P32239 3/20 0.49
▸ CHRND Q07001 4/20 0.48
▸ CHRNA1 P02708 1/20 0.48
▸ CHRNG P07510 1/20 0.48
▸ CHRNB1 P11230 1/20 0.48
▸ NPY4R P50391 4/20 0.47
▸ NPY1R P25929 3/20 0.47
▸ NPY2R P49146 3/20 0.47
▸ NPY5R Q15761 2/20 0.47
▸ ENPEP Q07075 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29816050 1.00 OPRD1 (0.49) OPRD1CCKARCCKBRCHRNDCHRNA1
SCHEMBL30661111 0.94 LNPEP (0.52) OPRD1CCKARCCKBR
SCHEMBL4293347 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RNPY5RENPEP
SCHEMBL29948864 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RNPY5RENPEP
SCHEMBL30252225 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RNPY5RENPEP
SCHEMBL4420809 0.91 ENPEP (0.56) NPY4RNPY1RNPY2RNPY5RENPEP
SCHEMBL29365741 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RNPY5RENPEP
SCHEMBL4293356 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RNPY5RENPEP
SCHEMBL266554 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RNPY5RENPEP
SCHEMBL266555 0.91 NPY4R (0.54) NPY4RNPY1RNPY2RNPY5RENPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116082505-A Binding members for PD-L1 细胞医学公司 2023-05-09 — — CN disclosed
CN-108699153-B Binding members of PD-L1 细胞医学瑞士公司 2022-09-23 — — CN disclosed
Send feedback